Lung Transplant Research at UPMC
An important facet of the lung transplant program at UPMC is its commitment to advancing the field of pulmonary transplantation through active grants, clinical research protocols, and quality assurance projects.
An area of intense focus is in preconditioning regimens that may reduce the incidence of chronic rejection as well as the need for immunosuppressive medications, thus reducing the drugs' toxicity. UPMC's published and ongoing efforts in the use of aerosolized cyclosporine as an immunosuppressant may also contribute to the body of lung transplant research.
UPMC lung transplant specialists also have taken steps to address some of the other major challenges facing lung transplantation today: the organ shortage, ischemia-reperfusion injury, and the damage organs suffer while they're in transit between donor and recipient.
It is through these efforts that our specialists gain greater insight into ways to provide better care for our patients.